US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist

87.970
+6.870+8.47%

Close Jan 24 16:00 ET

87.900
-0.070-0.08%

Post 20:01 ET

390.65BMarket Cap29.72P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Novo-Nordisk A/S Q4 2024 Estimates Date

Currency：USDFeb 5, 2025

	Estimate	YoY
Revenue	11.23B	+15.20%
EPS	0.85	+17.33%

Analyst Rating

Buy

Jan 24, 2025

Novo-Nordisk A/S Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: DKK

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 79.734B	--
Feb 5, 2025	2024/Q4	-- / 80.533B	--
Nov 6, 2024	2024/Q3	71.311B / 71.869B	--
Aug 7, 2024	2024/Q2	68.060B / 68.563B	--
May 2, 2024	2024/Q1	65.349B / 63.573B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 79.734B--

Feb 5, 20252024/Q4-- / 80.533B

Novo Nordisk Q4 2023 earnings conference call

Jan 31 06:00

Replay

Nov 6, 20242024/Q371.311B / 71.869B--

Aug 7, 20242024/Q268.060B / 68.563B--

May 2, 20242024/Q165.349B / 63.573B--

Unlock Free Earnings Estimates

Open Account

Novo-Nordisk A/S Earnings Reports

6-K: Financial Report for the Period 1 January 2024 to 30 September 2024

Nov 6, 2024 06:37 ET

6-K: Financial Report for the Period 1 January 2024 to 30 June 2024

Aug 7, 2024 06:56 ET

6-K: Novo Nordisk Stops the Ocedurenone CLARION-CKD Trial and Recognises Impairment Loss

Jun 26, 2024 13:22 ET

6-K: Financial Report for the Period 1 January 2024 to 31 March 2024

May 2, 2024 07:18 ET